255 related articles for article (PubMed ID: 2354925)
1. Biodistribution and clearance of liposomal gadolinium-DTPA.
Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
[TBL] [Abstract][Full Text] [Related]
2. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.
Unger EC; MacDougall P; Cullis P; Tilcock C
Magn Reson Imaging; 1989; 7(4):417-23. PubMed ID: 2811620
[TBL] [Abstract][Full Text] [Related]
3. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
4. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
[TBL] [Abstract][Full Text] [Related]
6. Clearance of liposomal gadolinium: in vivo decomplexation.
Unger EC; Fritz TA; Tilcock C; New TE
J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174
[TBL] [Abstract][Full Text] [Related]
7. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
Tilcock C; Unger E; Cullis P; MacDougall P
Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
[TBL] [Abstract][Full Text] [Related]
8. Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy.
Devoisselle JM; Vion-Dury J; Galons JP; Confort-Gouny S; Coustaut D; Canioni P; Cozzone PJ
Invest Radiol; 1988 Oct; 23(10):719-24. PubMed ID: 3192394
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
Unger E; Needleman P; Cullis P; Tilcock C
Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
[TBL] [Abstract][Full Text] [Related]
10. Detailed toxicity studies of liposomal gadolinium-DTPA.
Fritz T; Unger E; Wilson-Sanders S; Ahkong QF; Tilcock C
Invest Radiol; 1991 Nov; 26(11):960-8. PubMed ID: 1835967
[TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents.
Schwendener RA; Wüthrich R; Duewell S; Wehrli E; von Schulthess GK
Invest Radiol; 1990 Aug; 25(8):922-32. PubMed ID: 2394576
[TBL] [Abstract][Full Text] [Related]
12. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
Vion-Dury J; Masson S; Devoisselle JM; Sciaky M; Desmoulin F; Confort-Gouny S; Coustaut D; Cozzone PJ
J Pharmacol Exp Ther; 1989 Sep; 250(3):1113-8. PubMed ID: 2778711
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
14. An improved method for the preparation of liposomal gadolinium-DTPA. Ionophore-mediated active entrapment of gadolinium.
Tilcock CP; Ahkong QF; Parr M
Invest Radiol; 1991 Mar; 26(3):242-7. PubMed ID: 2055729
[TBL] [Abstract][Full Text] [Related]
15. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
17. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
Niemi P; Koskinen S; Reisto T
Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of pulmonary parenchyma and emboli by paramagnetic and superparamagnetic contrast agents.
Thakur ML; Vinitski S; Mitchell DG; Consigny PM; Lin S; DeFulvio J; Rifkin M
Magn Reson Imaging; 1990; 8(5):625-30. PubMed ID: 2082134
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver.
Kabalka GW; Davis MA; Holmberg E; Maruyama K; Huang L
Magn Reson Imaging; 1991; 9(3):373-7. PubMed ID: 1881256
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
